title: Using growth factor arrays and micropatterned co-cultures to induce hepatic differentiation of embryonic stem cells.
abstract: The success in driving embryonic stem cells towards hepatic lineage has been confounded by the complexity and cost of differentiation protocols that employ large quantities of expensive growth factors (GFs). Instead of supplementing culture media with soluble GFs, we investigated cultivation and differentiation of mouse embryonic stem cells (mESCs) on printed arrays of GFs. Hepatocyte growth factor (HGF), basic fibroblast growth factor (bFGF) and bone morphogenetic protein (BMP4) were mixed in solution with fibronectin and collagen (I) and then printed onto silane-modified glass slides to form 500 μm diameter protein spots. mESCs were cultured on top of GF spots for up to 12 days and analyzed by RT-PCR and immunostaining at different time points. The stem cells residing on HGF-containing combinations of GFs exhibited requisite features of hepatic differentiation including pronounced loss in pluripotency (Oct4), transient (up and down) expression of endoderm (Sox17) and upregulation of early hepatic markers--albumin and alpha-fetoprotein. The hepatic differentiation was enhanced further by adding hepatic stellate cells to surfaces that already contained mESCs on GF spots. A combination of co-culture with non-parenchymal liver cells and the optimal GF stimulation was found to induce endoderm and hepatic phenotype earlier and to a much greater extent than the GF arrays or micropatterned co-cultures used individually. While this paper investigated hepatic differentiation of mouse ESCs, our findings and stem cell culture approaches are likely to be relevant for human ESC cultivation. Overall, the platform combining printed GF arrays and heterotypic co-cultures will be broadly applicable for identifying the composition of the microenvironment niche for ESC differentiation into various tissue types.
authors.affiliation: Department of Biomedical Engineering, University of California-Davis, 451 Health Sciences Drive #2519, Davis, CA 95616, USA.
authors.forename: Nazgul
authors.initials: N
authors.lastname: Tuleuova
authors.forename: Ji Youn
authors.initials: JY
authors.lastname: Lee
authors.forename: Jennifer
authors.initials: J
authors.lastname: Lee
authors.forename: Erlan
authors.initials: E
authors.lastname: Ramanculov
authors.forename: Mark A
authors.initials: MA
authors.lastname: Zern
authors.forename: Alexander
authors.initials: A
authors.lastname: Revzin
mesh_terms: D000418:Albumins / Q000235:genetics; D000818:Animals; D019485:Bone Morphogenetic Proteins / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D018920:Coculture Techniques / Q000379:methods*; D053595:Embryonic Stem Cells / Q000166:cytology* / Q000187:drug effects; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D017228:Hepatocyte Growth Factor / Q000494:pharmacology; D022781:Hepatocytes / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D051379:Mice; D050814:Octamer Transcription Factor-3 / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D055760:SOXF Transcription Factors / Q000235:genetics; D000509:alpha-Fetoproteins / Q000235:genetics
chemical_list: D000418:Albumins; D019485:Bone Morphogenetic Proteins; D050814:Octamer Transcription Factor-3; D055760:SOXF Transcription Factors; D000509:alpha-Fetoproteins; D016222:Fibroblast Growth Factor 2; D017228:Hepatocyte Growth Factor